Moira Taicz

Moira Taicz

Auto-generated profile, based on publicly available information

Moira Taicz

Servicio de Infectologia, Hospital de Pediatría Juan P. Garrahan, Argentina

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2014 in Revista Iberoamericana de Micologia
Verified
Journal Article
Closed access
MTMoira Taicz
Moira Taicz
MRMaria Teresa Rosanova
Maria Teresa Rosanova
DBDavid Bes
David Bes
MLMaria Laura Lisdero
Maria Laura Lisdero
VIViviana Iglesias
Viviana Iglesias
GBGriselda Berberian
Griselda Berberian

15 February 2014 in Archivos Argentinos de Pediatria
Verified
Journal Article
Open access
Silvina RuvinskySilvina Ruvinsky
Silvina Ruvinsky
AMAndrea Monaco
Andrea Monaco
GPGuadalupe Perez
Guadalupe Perez
MTMoira Taicz
Moira Taicz
LILaura Inda
Laura Inda
RBRosa Bologna
Rosa Bologna
Inadequate antibiotic use is associated with an increased emergence of resistant microorganisms, higher morbidity and mortality rates, and an impact on public health.

1 June 2017 in Archivos Argentinos de Pediatria
Verified
Journal Article
Closed access
GBGriselda Berberian
Griselda Berberian
TRTeresa Rosanova
Teresa Rosanova
LILaura Inda
Laura Inda
CSClaudia Sarkis
Claudia Sarkis
HQHoracio Questa
Horacio Questa
MTMoira Taicz
Moira Taicz
Echinococcosis is a zoonotic disease that is widely spread across Argentina and worldwide. It is acquired during childhood but it is more common during adulthood. The pediatric population accounts for 10-20% of all cases. This study included 47 children diagnosed with echinococcosis over a 20-year period. Their median age was 8 years old (range: 3-17); most patients had some epidemiological history, such as having lived or living in an endemic or rural area and/ or having dogs that are fed with viscera. Findings included 85% of single cysts in only one parenchyma. Cysts were most commonly located in the liver and lungs. Medical/surgical treatment was carried out in 45 patients (96%). Subsequent complications were observed in 13 patients (28%), which were more common in those with lung cysts. Three patients (6%) relapsed 1-24 months later and required a new surgery. No patient died as a result of the parasitic disease.

1 January 2018 in Revista chilena de infectología
Verified
Journal Article
Open access
PDF file
MTMoira Taicz
Moira Taicz
MPM. Guadalupe Pérez
M. Guadalupe Pérez
VRVanesa Reijtman
Vanesa Reijtman
AMAlejandra Mastroianni
Alejandra Mastroianni
FEFlorencia Escarra
Florencia Escarra
RBRosa Bologna
Rosa Bologna
Palabras clave: Cáncer; bacteriemia; niños

1 December 2011
Verified
Journal Article
Closed access
Silvina RuvinskySilvina Ruvinsky
Silvina Ruvinsky
AMAndrea Mónaco
Andrea Mónaco
GPGuadalupe Pérez
Guadalupe Pérez
MTMoira Taicz
Moira Taicz
LILaura Inda
Laura Inda
RBRosa Bologna
Rosa Bologna

1 June 2015 in Archivos Argentinos de Pediatria
Verified
Journal Article
Closed access
Silvina RuvinskySilvina Ruvinsky
Silvina Ruvinsky
MTMoira Taicz
Moira Taicz
MPM Guadalupe Perez
M Guadalupe Perez
AMAndrea Monaco
Andrea Monaco
NENatalia Garcia Escude
Natalia Garcia Escude
RBRosa Bologna
Rosa Bologna
Casa Garrahan (CG) accommodates children with complex conditions referred nationwide; these children are seen in children's hospitals located in the Autonomous City of Buenos Aires. Varicella is a highly-contagious disease, with attack rates of up to 90% among susceptible individuals. In closed communities, the implementation of outbreak control measures is critical. To describe the characteristics of children exposed to varicella at CG, the implemented prophylaxis measures and their effectiveness. Prospective, cohort study. Children exposed to varicella at CG between2008 and 2013, their demographic and clinical characteristics, immunization and/or history of varicella, prophylaxis measures, and secondary attack rate were assessed. N: 107. Fifty-three percent (n: 57) were girls. Their median age was 84 months old [interquartile range (IQR): 24-144]. Ninety-five percent (n: 102) had an underlying disease [hemato-oncological disease: 39% (n: 42); neurological disease: 18% (n: 19); congenital heart disease: 9% (n: 10); and post-operative period: 65 (n: 6)]. Fifty percent had some degree of immunosuppression (n: 54). Twenty-nine percent (n: 31) referred to have had varicella; 27% (n: 29) indicated that they never had the infection; and 41% (n: 44) did not recall a history of varicella. Only 3% (n: 3) had been vaccinated. Based on their immune status, age and history of varicella, acyclovir was indicated as prophylaxis in 61% (n: 65); immunization in 10% (n: 10); and gamma globulin in 1 patient. No adverse effects were observed in relation to the different prophylaxis measures. No secondary cases were observed at 30 days. Implemented measures were effective to prevent secondary cases. Among healthy and immunocompromised children, prophylaxis with acyclovir was effective and well-tolerated.